Results 101 to 110 of about 155 (115)

Esketamine Nasal Spray Effective in Treatment-Resistant Depression

JAMA, 2019
openaire   +2 more sources

Esketamine nasal spray effective for rapid improvement of depressive symptoms

Clinical Pharmacist, 2019
openaire   +2 more sources

The Clinical and Economical Evaluation of Esketamine Nasal Spray: A Literature Review

2020
Maroney, Megan E, Bhavsar, Nisha, Niti Shah, Lee, Bona, Seoyoung Jeong   +4 more
openaire   +1 more source

Appraising esketamine nasal spray for the management of treatment-resistant depression in adults: Number needed to treat, number needed to harm, and likelihood to be helped or harmed

Journal of Affective Disorders, 2020
Jaskaran B Singh, Leslie Citrome, Allitia Dibernardo   +2 more
exaly  

Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3

American Journal of Geriatric Psychiatry, 2020
David Steffens, Jaskaran B Singh, Raphaël Gaillard   +2 more
exaly  

Esketamine nasal spray too costly for treatment-resistant depression

PharmacoEconomics & Outcomes News, 2020
openaire   +1 more source

A new indication for esketamine nasal spray (Spravato).

The Medical letter on drugs and therapeutics, 2020
openaire   +1 more source

Managing dissociative symptoms following the use of esketamine nasal spray: a case report

International Clinical Psychopharmacology, 2021
exaly  

Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression

JAMA Psychiatry, 2019
Andrea Fagiolini, John Zajecka, Jaskaran B Singh   +2 more
exaly  

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

International Journal of Neuropsychopharmacology, 2019
Jaskaran B Singh, Raphaël Gaillard, Arun Ravindran   +2 more
exaly